24 September 2025
A feasibility study of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients covered by Universal Coverage scheme
View Count
41
Share this research
Project Code
11-303-2554
Country
Thailand
Project Duration
Start : 1 January 2011
Research Status
Completed 100%
Complete Research Report
Quantity 1 files
Download Count
5 times
24 September 2025
A feasibility study of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients covered by Universal Coverage scheme
About Project
Content
The Cost-utility analysis (CUA) study of Hematopoietic stem cell transplantation (HSCT) versus blood transfusion and iron chelating therapy (standard treatment) found that related HSCT (sibling donor) is more cost effective than unrelated HSCT in patients ≤ 10 years old in Thai healthcare setting. However, there currently has capacity limit for HSCT provision in Thailand which can not meet all required patients. This situation hinders the implementation of HSCT provision under universal coverage (UC) scheme under National Health Security Office (NHSO) because the low accessibility to this therapy. Therefore, the CUA study is not cover some issues that the policy makers need to know before making the decision. This feasibility study serves the policy makers regarding the wider and comprehensive views besides CUA in order to consider about HSCT provision under UC scheme in Thailand.
Research Type
Others
Related Technologies
Medical Procedures
Funding Source
National Health Security Office (NHSO)
Research Team
Principal Researcher
Related Organizations/
Supporting Organizations
National Health Security Office (NHSO)
